Samsara Therapeutics
Treating Neurodegeneration by Improving Autophagy.
United Kingdom · $3.2M raised
- Employees
- 1–10
- Business Model
- B2B
- Website
- samsaratherapeutics.com
- Total Funding
- $3.2M
- Last Round
- $3.2M SeedJan 2019
- Rounds
- 1
About
UK biotech developing small-molecule autophagy activators to treat age-related neurodegenerative diseases.
Summary
Samsara Therapeutics is a Biotech company based in United Kingdom. It has raised $3.2M in total across 1 round, most recently a $3.2M Seed round in Jan 2019. Investors include Apollo Health Ventures.
Tech & App Stack
3 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jan 2019
Investors
Similar Companies
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
Biopharmaceutical company pioneering Helicon peptide drugs to target previously undruggable prote...